Planet Labs (PL) co-founder Schingler reports stock sale and trust transfer

Rhea-AI Filing Summary

Planet Labs PBC director and officer Robert H. Schingler reported insider transactions in Class A Common Stock. On 12/26/2025, he sold 73,782 shares at a weighted average price of $19.3548 per share under a Rule 10b5-1 trading plan adopted on July 14, 2025, leaving 1,164,729 shares beneficially owned directly.

On 12/29/2025, he transferred 330,171 shares from direct ownership to Ulysses Trust 02021.1, a revocable trust for which he and his spouse are trustees, and the same number of shares was reported as acquired by the trust at $0, resulting in 330,171 shares held indirectly. The directly held amount includes 834,558 RSUs that vest quarterly on March 15, June 15, September 15 and December 15, each RSU representing a right to receive one share of Class A Common Stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schingler Robert H

(Last) (First) (Middle)

C/O PLANET LABS PBC

645 HARRISON STREET, FLOOR 4

(Street)

SAN FRANCISCO CA 94107

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Planet Labs PBC [ PL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Co-Founder Chief Strategy Off.

3. Date of Earliest Transaction (Month/Day/Year)
12/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/26/2025		S		73,782(1)	D	$19.3548(2)	1,164,729(3)	D
Class A Common Stock	12/29/2025		J(4)		330,171	D	$0	834,558	D
Class A Common Stock	12/29/2025		J(4)		330,171	A	$0	330,171	I	Ulysses Trust 02021.1, Dated February 26, 2021

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2025.

2. The sales were executed in multiple trades at prices ranging from $19.05 to $20.31. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

3. Includes 834,558 RSUs that vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

4. This transaction involved a transfer of shares by the Reporting Person to Ulysses Trust 02021.1, Dated February 26, 2021, a revocable trust of which the Reporting Person and his spouse serve as trustees.

	/s/LeeAnn Linck, Attorney-in-fact for: Robert H Schingler	12/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Planet Labs PBC (PL) report for Robert H. Schingler?

Robert H. Schingler reported a sale of 73,782 shares of Planet Labs PBC Class A Common Stock on 12/26/2025 and a transfer of 330,171 shares to a revocable trust on 12/29/2025.

At what price did Robert H. Schingler sell Planet Labs PBC (PL) shares?

The 73,782 shares sold on 12/26/2025 were executed in multiple trades at prices ranging from $19.05 to $20.31, with a reported weighted average sale price of $19.3548 per share.

How many Planet Labs PBC (PL) shares does Robert H. Schingler beneficially own after these transactions?

After the reported transactions, Robert H. Schingler beneficially owns 1,164,729 shares of Class A Common Stock directly and 330,171 shares indirectly through Ulysses Trust 02021.1.

What is the nature of the trust involved in the Planet Labs PBC (PL) insider filing?

The transfer involved Ulysses Trust 02021.1, Dated February 26, 2021, a revocable trust of which Robert H. Schingler and his spouse serve as trustees, which now holds 330,171 shares indirectly.

Were the Planet Labs PBC (PL) insider sales made under a Rule 10b5-1 trading plan?

Yes. The filing states that the 12/26/2025 transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by Robert H. Schingler on July 14, 2025.

What restricted stock units (RSUs) are reported for Robert H. Schingler at Planet Labs PBC (PL)?

The filing states that his holdings include 834,558 RSUs, which vest in equal quarterly installments on the 15th of March, June, September and December, each RSU representing a right to receive one share of Class A Common Stock.